The system is designed to enable direct access to radial artery in wrist with guiding catheter without use of introducer sheath
Cordis, a Cardinal Health company will begin marketing the technologically advanced Railway Sheathless Access System in India this year.
Cordis’ Railway System is indicated for use in radial artery procedures requiring percutaneous introduction of intravascular devices.
A percutaneous procedure is a method that allows doctors to insert a medical device into a patient’s blood vessel by using a needle, a guide-wire, an introducer sheath and a catheter. The catheter is used to deliver medication or implant a stent into the blood vessel.
The innovative Railway System is designed to enable direct access to the radial artery in the wrist with a guiding catheter without the use of an introducer sheath. This reduces the size of the arterial puncture site by up to 2F compared to a conventional sheath system.
The Railway System received the European CE Mark approval in March 2017 and the US Food & Drug Administration clearance in April 2018. The Railway System will be available in India later this year.
“In our experience the Cordis Railway Sheathless Access System minimises the radial artery trauma and disruption, by reducing artery puncture size up to 2F (33 per cent) while allowing larger bore guide catheter use during trans-radial coronary procedures. In our study the Railway system reduced the incidence of spasms, radial trauma and improved the trans-radial access success rate for complex coronary procedures. This resulted in reduced vascular complications, leading to early ambulation and discharge from the hospital. ” said Dr Kintur Sanghvi, Associate Medical Director of Interventional Cardiology and Endovascular Medicine, Deborah Heart & Lung Center in Browns Mills, New Jersey.
“Cardinal Health is a leader in the cardiovascular and endovascular spaces. Our goal is to bring the best medical devices to India. We hope that by introducing the Railway system in India we will be able to help improve patient outcomes and provide Indian doctors with better treatment options for people suffering from heart disease.” said Clara Tan, Managing Director, Emerging Asia, Cardinal Health.